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Recent work has shown that histone methylation is an important regulator of transcription. While much is
known about the roles of histone methyltransferases (HMTs) in the establishment of heterochromatin, little is
known of their roles in the regulation of actively transcribed genes. We describe an in vivo role of the Sac-
charomyces cerevisiae HMT, Set2. We identified SET2 as a gene necessary for repression of GAL4 basal
expression and show that the evolutionarily conserved SACI, SACII, and SET domains of Set2 are necessary
for this repression. We confirm that Set2 catalyzes methylation of lysine 36 on the N-terminal tail of histone
H3. Conversion of lysine 36 to an unmethylatable arginine causes a decrease in the repression of GAL4
transcription, as does a set2 mutation. We further show that lysine 36 of histone H3 at GAL4 is methylated
and that this methylation is dependent upon the presence of SET2.
The DNA of eukaryotic cells is organized into two different
states: a highly condensed form called heterochromatin that is
generally transcriptionally inactive and a less condensed form
called euchromatin that is generally transcriptionally active. In
both cases the fundamental unit of chromatin is the nucleo-
some, composed of 146 bp of DNA wrapped around a histone
octamer consisting of two copies of each histone protein, H2A,
H2B, H3 and H4 (39). Ordered nucleosomes are generally
repressive but can be modified in a number of ways to alter
rates of transcription (36). Posttranslational modifications of
histone N-terminal tails are important mechanisms by which
transcription of open chromatin is modulated (9, 32).
Methylation of specific lysines of histone proteins can target
chromatin for activation or repression of transcription (11, 43).
The effects of methylation are believed to be a result of either
direct changes in protein structure or, in some cases, creation
of a binding site for proteins with a chromodomain (2, 15, 24).
For example, methylation of lysine 9 of histone H3 recruits
HP1 via its chromodomain and establishes heterochromatin in
flies and mammals (2, 15). Similarly, in Schizosaccharomyces
pombe, the histone methyltransferase (HMT) Clr4 methylates
H3 lysine 9 and this serves as a binding site for the HP1-like
protein, Swi6 (24).
The highly conserved SET domain is found in many proteins
implicated in modulating chromatin structure, including mem-
bers of the Polycomb and Trithorax groups of proteins, and
proteins involved in position effect variegation and gene silenc-
ing in budding and fission yeasts (8). The SET domain is
associated with lysine HMT activity (23, 25, 33, 34, 37, 41), and
it interacts with the N-terminal tails of histones, signaling pro-
teins, components of nucleosome remodeling factors, and pro-
teins involved in DNA damage repair (4, 10, 29).
Saccharomyces cerevisiae has six proteins with a SET do-
main, two of which have been characterized. Set1 catalyzes
methylation of lysine 4 of H3 and has been correlated with
transcriptional activity (3, 12, 27, 30). Set2 methylates lysine 36
of H3 and represses transcription when tethered to a reporter
gene (33). Several recent papers have shown that Set2 binds to
RNA polymerase II and specifically to the elongating form of
the C-terminal tail of the largest subunit (17, 18, 40). The
functional significance of this binding and of H3 lysine 36
methylation is not known. Here we describe experiments show-
ing that methylation by Set2 is required for repression of basal
transcription of a specific gene, GAL4.
MATERIALS AND METHODS
Plasmid construction. Unless specified, all PCRs were performed with Pfu
Turbo DNA polymerase (Stratagene) according to the manufacturer’s instruc-
tions. The DNA sequence of each cloned PCR product was determined to ensure
the fidelity of the polymerase.
Using primers 5-GCGCGGATCCATGTCGAAGAACCAAAGTG-3 and
5-TTAAGCGGTGAGCCAATATGAGTCGACGCGC-3, the recombinant
glutathione S-transferase (GST)–Set2 expression vector was constructed by am-
plifying the first 900 bases of the SET2 open reading frame (ORF) from yeast
genomic DNA. Using the BamHI and SalI sites, the amplicon was then sub-
cloned into pGEX-KG, resulting in an in-frame N-terminal fusion with GST.
Primer pair JL154 (5-GATGGCGTCAACCATGCCTATGACGAGGATTCT
GACTGT-3) and JL155 (5-ACAGTCAGAATCCTCGACATAGGCATGGT
TGACGCCATC-3) and primer pair JL113 (5-GCCAGATTTTGCAATCACT
CTGCCAGCCCCAATGCATATGTT-3) and JL114 (5-AACATATGCAT
TGGGGCTGGCAGAGTGATTGCAAAATCTGGC-3) were subsequently
used (together with GST-Set2 as a template for site-directed mutagenesis) to
generate pJWL129 (GST-Set2 C82Y) and pJWL108 (GST-Set2 C201A), respec-
tively.
Recombinant Drosophila histone expression vectors pJWL124 (H3 K9R),
pJWL110 (H3 K27R), and pJWL112 (H3 K36R) were constructed by site-
directed mutagenesis using a wild-type H3 expression plasmid, pdH3, as a tem-
plate (16), and amplification was performed using primer pair JL144 (5-ACC
AAGCAAACTGCTCGCAGATCGACTGGTGGAAAGGCG-3) and JL145
(5-CGCCTTTCCACCAGTCGATCTGCGAGCAGTTTGCTTGGT-3),
primer pair JL111 (5-GCTACTAAGGCCGCTCGCAGGAGTGCTCCAGCC
ACCGGA-3) and JL112 (5-TCCGGTGGCTGGAGCACTCCTGCGAGCGG
CCCTAGTAGC-3), and primer pair JL135 (5-GCGATAGCGGTGGGGCT
* Corresponding author. Mailing address: Department of Biochem-
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TCCTCACACCTCCGGTGGCTGG-3) and JL136 (5-CCATCTACCGG
TGGTGTTAGGAAGCCTCACAGATATAAG-3), respectively. pJWL113
(H3 K27,36R) was constructed using pJWL110 as a template and primer set
JL135 and JL136.
The yeast histone expression plasmid pJWL116 (pRS314 hht2 K36R-HHF2) is
derived from pRM200 (pRS314 HHT2-HHF2). Using the EcoRI and SalI sites,
the EcoRI-SalI fragment containing HHT2 and HHF2 from pRM200 was sub-
cloned into pUC18 to generate pASB121. pASB121 was then used as a template
together with primers JL137 (5-CAATCTACCGGTGGTGTTAGGAAGCC
TCACAGATATAAG-3) and JL138 (5-CTTATATCTGTGAGGCTTCCT
AACACCACCGGTAGATGG-3) for site-directed mutagenesis to make the
H3 K36R mutation. Using the EcoRI and SalI sites, the insert containing hht2
K36R-HHF2 was reintroduced into the pRM200 backbone to generate
pJWL116.
The yeast SET2 plasmid pBM3352 contains the yeast SET2 ORF, 600 bp
upstream of the initiating methionine, and 200 bp downstream of the stop codon.
pBM3354 is identical to pBM3352 with the exception of C82Y and D83Q amino
acid conversions. pBM3352 was used as a template together with primers JL154
and JL155 for site-directed mutagenesis to generate pJWL130. Using the SacI
and XhoI sites, the SET2-containing fragments from pBM3352, pBM3354, and
pJWL130 were then subcloned into pRS412 to generate pJWL133, pJWL132,
and pJWL134, respectively.
The yeast plasmid pBM3670 used for cloning mutagenized SET domain frag-
ments of SET2 had the DNA encoding amino acids (aa) 42 to 263 of Set2 deleted
and replaced with a HIS3 gene flanked by MluI sites. The HIS3 gene was
amplified using primers OM1358 (5-CCTCAAAGGCTTTTTGATCAAGAGC
CTGATCTCACAGAGGAAGCATTGACGCGTGGCCTCCTCTAGTACAC
TC-3) and OM1360 (5-GGCATCAGCGATGTTCTGGGGCAATAAAGA
TGCCGCATCTGTTTGACGCGTGCGCGCCTCGTTCAGAATG-3). The
PCR product was then introduced with pBM3352 into YM6119 (MAT ura3-52
his3200 ade2 lys2 leu2 trp1-901 met-gal80-538 set2::GFPHIS3 UAS-
GAL4URA3), and transformants were selected for growth on synthetic dex-
trose (SD)-His-Trp. A few clones were recovered from yeast and transformed
into Escherichia coli DH5. Clones were sequenced in their entirety to confirm
the correct integration of the HIS3 gene, and a single transformant was chosen and
designated pBM3670.
Genetic screens. Selection for repressors of basal GAL4 transcription was
performed by plating YM3108 (MATa ura3-52 his3200 ade2 lys2 trp1-901 met-
gal80-538 CANR LEU2::GAL1-lacZ UAS-GAL4URA3) on minimal medium
with complete amino acids and 2% galactose. Gal revertants were isolated at a
frequency of about 106. Three suppressor mutants were isolated and found to
be recessive, unlinked to GAL4, and in the same complementation group. The
strongest suppressor, designated YM3242, was plated to 5-FOA, and resistant
colonies were isolated. This was necessary to remove the URA3 marker used in
the UAS gal4 integration. The resulting strain, YM4068, was then transformed
with a YCp50 genomic library, and transformants were screened for the Gal
phenotype by replica plating to SD-Ura and synthetic complete (SC)-Ura with
2% galactose (28). Plasmids from Gal isolates were then isolated from yeast
and recovered in E. coli DH5. Many plasmids with similar restriction patterns
were isolated, and the plasmid with the smallest insert (pBM2302) was digested
to generate the smallest complementing fragment (designated 1-1). The DNA
sequence of this fragment was determined and was found to contain ORF
YLJ168C. Using gap repair, this ORF was then isolated from the set2-1 mutant
YM3242 and sequenced to identify the C82Y set2-1 mutation.
Using standard methods, mutagenesis of SET2 was performed on pBM3352 by
transformation into the E. coli XL1Red mutator strain. Transformants were
washed from the plates and pooled into one large culture. This pool of trans-
formants was grown overnight at 37°C in Luria broth with 50 g of ampicillin/ml,
and plasmid DNA was produced from a large-scale preparation. This library of
mutants served as a template for PCR using OM1100 (5-GGGCAATTGATG
TCGAAGAACCAAAGT-3) and OM1233 (5-GGGCAATTGGCTTAATTTC
TTTAACTTTAGCCA-3). The PCR product was used to gap repair an MluI
digest of pBM3670 in strain YM6119. Transformants were selected for growth on
SC-Trp with 2% galactose. Plasmids from Gal transformants were recovered
from yeast and subsequently transformed into E. coli DH5. The set2 ORFs were
sequenced in their entirety.
Yeast strain construction. GAL4 reporter strains for the experiments were
derived from RMY200 (MATa ade2-101 his3200 lys2-801 trp1901 ura3-52
hht1-hhf1::LEU2 hht2-hhf2::HIS3 [pRM200]) (see Fig. 4). First, pRM200 was
replaced with pMS329 (pRS316-HHF2-HHT2) to create strain yJL126. Using the
kanMX6 knockout cassette (19), the SET2 ORF was then deleted from strain
yJL126 to create yJL99. This strain was transformed with pRM200 and pJWL116
to Trp and FOAR, generating yJL103 and yJL116, respectively. yJL103 and
yJL116 were transformed with the SacI-KpnI fragment from pBM2012 (selecting
for Ura) to create yJL109 and yJL121. pBM2012 is identical to pBM1974 ex-
cept that the upstream activation sequence (UAS) region (bases 139 to 414)
of the GAL4 promoter has been deleted. Correct recombination of the UAS
gal4::cat reporter at the endogenous GAL4 gene in yJL109 and yJL121 was
confirmed by Southern blotting. yJL109 and yJL121 were each transformed with
pRS412, pJWL133, pJWL132, and pJWL134. Multiple transformants were then
assayed for chloramphenicol acetyltransferase (CAT) activity.
Strains used in chromatin immunoprecipitations were derived from YM4192
[MATa ura3-52 his3-200 ade2-101 lys2-801 trp1-901 met 15 gal80-538 CANR
UAS (139 to 187) gal4::catURA3 LEU2::GAL1-lacZ] (5). BCY1 was
made by using the kanMX6 knockout cassette to delete SET2 from YM4192 (19).
Expression and purification of recombinant proteins. Plasmids expressing
recombinant GST-Set2, GST-Set2 (C82Y), GST-Set2 (C201A), and GST-Clr4
were transformed into BL21(DE3) Codon RIL (Stratagene catalog no. 230245).
Expression was performed in 250-ml cultures of Luria broth with 50 g of
ampicillin/ml and 34 g of chloramphenicol/ml. The cultures were grown at room
temperature to an optical density at 600 nm of approximately 0.2 and then chilled
on ice. Ethanol and IPTG (isopropyl--D-thiogalactopyranoside) were added to
achieve final concentrations of 3% (vol/vol) and 0.45 mM, respectively. The cul-
tures were induced at 18°C overnight with gentle mixing. The cells were pelleted
at 5,000 	 g for 10 min at 4°C, resuspended in 20 ml of ice-cold 1	 phosphate-
buffered saline, and then lysed by sonication. Insoluble material was removed by
centrifugation at 12,000 	 g for 20 min at 4°C. Fusion proteins were purified on
a column using 1 ml of glutathione Sepharose (Amersham catalog no. 17-5132-
01) according to the manufacturer’s instructions. Eluted proteins were dialyzed
in 4 liters of 1	 phosphate-buffered saline at 4°C. Glycerol and dithiothreitol
were added to the purified protein to achieve final concentrations of 10% (vol/
vol) and 1 mM, respectively. Protein concentrations were estimated with poly-
acrylamide gel electrophoresis using bovine serum albumin standards. The pu-
rified proteins were frozen in liquid nitrogen and stored at 80°C.
Recombinant Drosophila histones were expressed from pdH3, pdH4, pJWL110,
pJWL112, and pJWL124 as described previously (16). Approximately equal
quantities of wild-type and mutant H3 and wild-type H4 were purified, solubi-
lized, and renatured into H3/H4 tetramers according to established procedures
(20). The concentration of the tetramers was estimated with polyacrylamide gel
electrophoresis using bovine serum albumin standards.
Enzyme assays. Methyl transfer reactions were performed at 30°C for 1 h in
50-l volumes containing 50 mM Tris-Cl (pH 8.5), 20 mM KCl, 10 mM MgCl2,
10 mM -mercaptoethanol, 250 mM sucrose, 1.1 Ci of S-adenosyl-L-[methyl-
3H]methionine (Amersham catalog no. TRK865) (82.0 Ci/mmol), 1.5 g of re-
combinant Drosophila H3/H4, and 5 g of GST-Set2, GST-Set2(C82Y), GST-
Set2(C201A), GST-Clr4, or GST. Proteins were precipitated by the addition of
1 ml of cold 20% trichloroacetic acid and incubation on ice for 30 min, filtered
using glass filters on a vacuum manifold, and washed three times with 3 ml of 5%
trichloroacetic acid followed by three washes with 3 ml of methanol. The filters
were allowed to air dry and added to 4 ml of Ecoscint. Tritium was quantified
using a liquid scintillation counter.
Extracts for the CAT assays of UAS gal4::cat reporter strains were made as
described previously (6). A total of 20 g of protein from the extracts was assayed
using a FAST CAT (deoxy) assay kit (Molecular Probes catalog no. F-6616)
according to the manufacturer’s instructions. Activity is expressed as the amount
of acetylated BODIPY FL 1-deoxychloramphenicol fluorescence.
Chromatin immunoprecipitation. Samples were processed for chromatin im-
munoprecipitation as described previously (13). In brief, YM4192 and BCY1
were grown in 200 ml of yeast extract-peptone-dextrose to an A600 of 0.8 and
then fixed with formaldehyde. Whole-cell extracts were made from fixed cells and
sonicated to shear the chromatin to an average size of 400 bp. Using 1 l of
anti-H3 methyl lysine 36 antibody (a generous gift from B. Strahl) and protein
A-Sepharose, a total of 1/10 of the sheared chromatin was then immunoprecipi-
tated in a 200-l volume. Following immunoprecipitation, the cross-links were
reversed and the DNA fragments were extracted for PCR.
PCR amplification of target loci was accomplished using Herculase polymer-
ase (Stratagene) and the following primer sets: for ACT1, 5-CCAATTGCTCG
AGAGATTT-3 and 5-CATGATACCTTGGTGTCTTG-3; for HMR-E, 5-T
GCAAAAACCCATCAACCTTG-3 and 5-ACCAGGAGTACCTGCGCTTA-
3; for cat, 5-CTTGCCCGCCTGATGAATGCTC-3 and 5-GCCTTGCGTAT
AATATTTGCC-3; and for the GAL4 promoter, 5-AGTTTCAAAACGTCCG
CGTC-3 and 5-CGATAGAAGACAGTAGCTTC-3. Products were resolved
on a 1.5% agarose gel and visualized with ethidium bromide.
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Set2 is a repressor of GAL4 transcription. The GAL4 pro-
moter, which does not seem to contain a TATA box, is regu-
lated by three cis-acting elements: a UAS necessary for maxi-
mal GAL4 expression, an upstream essential sequence that is
essential for GAL4 expression, and Mig1 binding sites that
mediate glucose repression of GAL4 expression (5). Mutants
from which the GAL4 UAS has been deleted have a low basal
level of GAL4 expression that is insufficient to support the
utilization of galactose (5). These mutants revert to a Gal
phenotype at a frequency of approximately 106 per plated
cell. The mutations responsible for suppression of the Gal
phenotype caused by the UAS deletion are all recessive, im-
plying that they affect genes encoding negative regulators of
GAL4 transcription.
The gene corresponding to one of the mutant complemen-
tation groups was isolated and found to be SET2. The strongest
mutant allele was designated set2-1. Assays were conducted to
evaluate the effects of set2-1 on GAL4 expression levels by
using strains with a gal4-cat reporter gene and measuring CAT
activity. Consistent with our expectation that Set2 is a negative
regulator of GAL4 expression, the set2-1 allele significantly
increased expression of a UAS-less GAL4 gene (0.2 U of CAT
activity [31] compared to 0.02 U for a comparable SET2
strain). This mutation does not increase activity from an intact
GAL4 promoter (1.4 U compared to 1.6 U for a wild-type
SET2 strain), suggesting that Set2 affects basal, but not acti-
vated, GAL4 expression. Set2 does not appear to be a global
repressor of gene expression, because the set2-1 mutation did
not affect expression of three other genes we tested (GCN4,
CTS1, and HIS3) and Ty1 (data not shown).
The SET and SAC domains of Set2 are necessary for the
repression of GAL4. The Set2 protein contains a highly con-
served SET domain, flanked by two SAC (SET domain-asso-
ciated cysteine-rich) domains (Fig. 1). SAC domains are found
in many, but not all, SET-containing methyltransferases (25,
37) and have been shown to be essential for in vitro activity
(24). The set2-1 allele results in a C82Y conversion in the SACI
domain of Set2 protein (Fig. 1). Because the set2-1 mutation
resides in the SAC domain, we wanted to identify other resi-
dues in the SAC and SET domains that are necessary for
repression of GAL4 expression. To do this, we mutagenized
the SAC and SET domains and selected nonfunctional set2
mutants by the method used to isolate set2-1. The region of
SET2 encoding the SAC and SET domains (aa 1 to 296) was
amplified using mutagenic PCR, and the product was inserted
into a SET2-containing plasmid (pBM3670) by recombination
(gap repair; see Materials and Methods for details). Plasmids
containing nonfunctional set2 genes were selected as Gal
transformants and rescued in E. coli DH5, and their set2
DNA sequences were determined.
Most of the recovered mutations affected highly conserved
amino acids in the SAC and SET domains (Fig. 1). Mutated
residues in the SACI domain were predominantly cysteines
(including cysteines 82, 88, 97, and 109). SACII domain mu-
tations also predominantly affected cysteines (including cys-
teines 248, 250, and 255). Amino acid conversions in the SET
domain, while more variable, were most often found in highly
conserved amino acids (including residues G151, F196, H199,
S200, G219, and E231) but also in less conserved residues
(H170, C197, and Q223).
Biochemical characterization of the SAC and SET domains
of Set2. We found that purified recombinant GST-Set2 has
robust methyltransferase activity on chicken erythrocyte his-
tones. Analysis of the methylated histones by triton acid urea
electrophoresis revealed that the predominant substrates are
H3 and, to a much lesser extent, H4 (data not shown).
To confirm that the HMT activity detected was due to Set2,
we introduced two single-amino-acid changes in highly con-
served cysteines located in the SAC and SET domains. We
chose to mutate C82 (because it is mutated in set2-1) as well as
C201 (because previous studies determined that the corre-
sponding mutation abolished the enzymatic activity of the
Suv39 h1 and G9a HMTs [26, 34]). Each of these mutants was
assayed for its ability to methylate recombinant H3/H4 tetram-
ers. Both mutations resulted in a complete loss of HMT activ-
ity, showing that the in vitro activity we detected was due to
Set2 (Fig. 2). The fact that the set2-1 mutation abolished in
vitro activity suggests that Set2 enzymatic activity is essential
for repression of GAL4.
The catalytic domain of Set2 predominantly methylates ly-
sine 36 on H3. We used GST-Set2 to methylate recombinant
H3 and determined that lysine 36 was methylated (data not
shown), confirming a previous report (33). To complement this
analysis, we undertook a mutational analysis of the H3 N-
terminal tail. Single lysines 9, 27, and 36 and lysines 27 plus 36
on recombinant H3 were converted to arginine. The resulting
mutated H3 proteins were expressed and mixed with wild-type
recombinant H4 and then used as the substrates in methyl-
transferase reactions with GST-Set2. In agreement with the
results from the sequence data, GST-Set2 does not transfer
methyl groups to histones with lysine 36 on H3 converted to
arginine (Fig. 3). As a control, the well-characterized Clr4
methyltransferase (24) was able to methylate H3 except when
lysine 9 is converted to arginine (Fig. 3).
Histone H3 lysine 36 is essential for GAL4 repression by
SET2. To test the effect of the histone H3 lysine 36 mutation on
GAL4 transcription, a UAS gal4::cat reporter was introduced
into strains which contained four different SET2 alleles: SET2,
set2 C82Y, set2 C201A, and set2. Each strain also contained
either wild-type HHT2 or an hht2 K36R mutation. Extracts
from multiple transformants of each reporter strain were
tested for CAT activity.
While the set2 mutation caused a significant increase in
CAT activity in a HHT2 strain, the methyltransferase-defective
set2 alleles differed somewhat in their abilities to repress cat
expression. The set2 C82Y allele had the same levels of cat
expression as the set2 allele, providing additional evidence
that the methyltransferase activity of Set2 is necessary for its
repressive effects on UAS gal4::cat. The set2 C201A allele
was found to have 50% repressive ability (Fig. 4), while this
mutant protein was completely defective in vitro (Fig. 2). Pos-
sibly this allele is less defective in vivo than it is in vitro (see
Discussion).
The hht2 K36R mutation caused a significant increase in
CAT activity in the UAS gal4::cat reporter strain. This in-
crease in activity is independent of the SET2 allele, demon-
strating that the ability to methylate lysine 36 is epistatic to
SET2 and placing the hht2 K36R allele downstream of SET2 in
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the pathway of repression of UAS gal4::cat. It is interesting
that the set2 hht2 K36R strain has lower CAT activity than
the set2 HHT2 strain (Fig. 4). This could be due to a global
effect on gene expression because of the presence of the mu-
tated H3 throughout the genome.
We next used chromatin immunoprecipitation to show that
histones in the UAS gal4::cat chromatin are a direct target of
Set2 methylation. Using an antibody specific to H3 methyl
lysine 36, we were able to selectively precipitate the UAS
gal4::cat promoter and coding region from extracts of a SET2
strain but not from those of a set2 strain (Fig. 5). The loss of
methylation at lysine 36 in the set2 strain demonstrates a
direct involvement of Set2 in the modification of the UAS
gal4::cat region. These data support previous results demon-
strating that Set2 methylates H3 at the promoter and coding
region of GAL4 (40). In our experiments HMR-E was not
precipitated in a SET2 background and served as a negative
control. It is interesting that we also precipitated sequences
from the ACT1 ORF in a SET2 strain, suggesting that ACT1 is
also a target of Set2 methylation.
DISCUSSION
We first identified SET2 in a selection for genes involved in
the basal repression of GAL4. Three set2 mutants were iso-
lated, the strongest of which was designated set2-1, which
changes a highly conserved cysteine residue (C82) in the cat-
alytic domain of Set2 to tyrosine. This suggests that Set2 re-
presses basal transcription of GAL4 through its methyltrans-
ferase activity.
We identified other residues in the catalytic domain that are
necessary for GAL4 repression (Fig. 1). Conserved cysteine
residues found in the SACI and SACII domains and highly
conserved residues located in the SET domain are important
for Set2 function. The structures of several SET domain pro-
teins have been determined recently (7, 14, 21, 22, 35, 38, 42),
FIG. 1. Mutations that affect SET2 function cluster at conserved residues within the SAC and SET domains. (A) The first 296 aa of Set2 contain
a SET domain flanked by two SAC domains, I and II. (B) Lineup of the SAC and SET domains from a selection of SET domain-containing proteins
that have been demonstrated to have methyltransferase activity. The lineup was made with the ClustalW alignment program followed by hand
editing. A consensus sequence is shown below the lineup. Mutations isolated in this study are designated by small arrows above the sequence. The
large arrows identify amino acids that were also mutated in the E. coli Set2 expression plasmid and tested for HMT activity.
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and two of the solved structures, S. pombe Clr4 and Neurospora
crassa Dim-5, contain cysteine-rich SAC domains. The struc-
tures show that cysteines in the N-terminal SAC domain have
a structural role in coordinating the binding of a triangular zinc
cluster, while the cysteine corresponding to C201 in Set2 has
been suggested to contact the C-terminal cysteine-rich SAC
domain to form a cofactor-substrate binding site (22, 42).
Given this structural information, we believe that the C82Y
mutant alters the zinc cluster structure and that the enzyme
loses activity because of structural changes. On the other hand,
the C201A mutation should cause minimal structural changes
but the purified protein may be unable to form an intact co-
factor or substrate binding site in vitro. It is possible that such
a binding site can be restored to some degree in vivo in the
presence of other proteins. These structure-based interpreta-
tions are consistent with our results shown in Fig. 4. In addi-
tion, three of the mutations recovered in the selection, C97,
H199, and Q112 (similar to Clr4 R320), were found to ablate
HMT activity in previously characterized HMT enzymes, lead-
ing us to believe that the defects in set2 affect catalysis rather
than protein-protein interactions (24, 25, 41).
We found that the catalytic domain of Set2 has HMT activity
in vitro (Fig. 2) and, in agreement with a recent report (33),
that the prominent site of methylation is lysine 36 on histone
H3. We showed that GST-Set2 cannot methylate a histone H3
substrate when lysine 36 is converted to an unmethylatable
arginine, confirming its preference for lysine 36 (Fig. 3).
We believe that the HMT activity of Set2 on H3 lysine 36 is
responsible for its basal repression of GAL4 for four reasons.
First, the set2-1 mutant (C82Y) isolated in our original screen-
ing, as well as the C201A mutant, is catalytically inactive in
vitro (Fig. 2). Second, these catalytically inactive mutants have
a significantly reduced ability to repress the UAS gal4::cat
reporter gene (see Results and Fig. 4). Third, the ability of Set2
to repress GAL4 expression is dependent on the availability of
lysine 36 on H3 for methylation, because the hht2 K36R
change causes a loss of repression of the UAS gal4::cat re-
FIG. 2. Mutations in the SET and SAC domains result in loss of
GST-Set2 methyltransferase activity. (Upper panel) The locations of
the two amino acid changes made to highly conserved cysteine residues
in the GST-Set2 expression plasmid are indicated. (Lower panel) GST-
Set2, GST-Set2 (C82Y), GST-Set2 (C201A), and a GST control pro-
tein were purified and assayed for methyltransferase activity. The bar
graphs represent averages of three independent assays.
FIG. 3. GST-Set2 preferentially methylates lysine 36 of H3. (A)
GST-Set2 was used to methylate recombinant wild-type (W.T.) and
mutant histone H3/H4 tetramers. Levels of GST-Set2 activity on the
various histone H3 mutants are indicated. Activity was lost when lysine
36 was mutated to the unmethylatable arginine. (B) Clr4 was used as
a control to monitor the quality of the histone tetramers. Methylation
reactions were performed as described for Fig. 2 except that recombi-
nant GST-Clr4 was used instead of GST-Set2. Consistent with pub-
lished results, GST-Clr4 was unable to methylate the H3 K9R mutant.
For each panel, the bar graph represents the averages of two experi-
ments.
FIG. 4. Methyltransferase activity of Set2 and the presence of ly-
sine 36 on histone H3 are required for the repression of UAS gal4::
cat. CAT assays were performed on extracts from UAS gal4::cat
reporter strains containing SET2, set2 C82Y, set2 C201A, and set2
alleles in an HHT2 or hht2 K36R background. The data show dere-
pression of UAS gal4::cat with enzymatically defective Set2 mutants.
In addition, significant derepression of the reporter was seen with the
introduction of an unmethylatable arginine at residue 36 on H3. The
bar graph represents the averages of four independent experiments.
W.T., wild type.
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porter gene that is the same whether the SET2 gene is present
or has been deleted (Fig. 4). Finally, the chromatin immuno-
precipitation experiments show that SET2 is directly responsi-
ble for methylation of lysine 36 at the GAL4 gene (Fig. 5). The
combination of genetic and biochemical evidence strongly sug-
gests that repression of GAL4 by Set2 is mediated by methyl-
ation of lysine 36 on histone H3.
The repressive effects of Set2 methylation on transcription in
vivo are in agreement with a previous report (33). In that
report, LexA-Set2 was found to repress transcription 20-fold
when tethered to a CYC1-lexAop-lacZ reporter. The differences
in the level of repression by Set2 at GAL4 and CYC1-lexAop-
lacZ may be due to differences in the recruitment of Set2 to
these promoters. In agreement with our results, a C201A mu-
tation in LexA-Set2 resulted in a 50% loss in repression (33).
This partial effect could be due to the different activity levels of
the mutant protein in vitro (where it was completely defective;
Fig. 2) versus that seen in vivo. Or perhaps Set2 has a repres-
sion function independent of its methylation activity.
It is not easy to reconcile our results regarding the repres-
sion of basal transcription of GAL4 with the numerous recent
reports that Set2 binds to the elongating form of RNA poly-
merase II (17, 18, 40). Perhaps Set2 acts as a backup system for
transcriptional repression. Under conditions of repression,
transcriptional repressors bind to the promoter region of reg-
ulated genes, preventing the assembly and subsequent clear-
ance of an RNA polymerase II transcription complex. But
occasionally, “leaky” transcription can occur under repressive
conditions. Perhaps Set2 methylates the promoter and the
coding part of the gene when this leaky transcription occurs,
thus marking the chromatin and preventing subsequent tran-
scription. It is also possible that the methylation of lysine 36 by
Set2 has different functions at promoters than at coding re-
gions of genes.
The actual repression mechanism resulting from lysine 36
methylation is still not known. One model is that the methyl-
ation of lysine 36 causes an alteration of nucleosome structure
that is repressive in nature. To test this hypothesis, we con-
ducted MNase protection assays on hht2 K36R set2 and
HHT2 SET2 strains at the GAL4 promoter. We found no
difference in digestion patterns, suggesting that nucleosome
positioning had not been altered in the absence of methylation
(data not shown). It is still possible that K36 methylation
changes chromatin structure in a way that cannot be detected
with MNase assays. A second model is that methylation of
lysine 36 might recruit a chromodomain-containing protein
that acts as a repressor of transcription. This would be similar
to the mechanism used for the establishment of heterochro-
matin by HP1 binding to methyl lysine 9 on H3 (2, 15, 24).
In summary, we have shown that Set2 methylation is in-
volved in the repression of basal transcription of GAL4. The
fate of the methylated histones under conditions of transcrip-
tional activation is unknown. It is possible that methylation of
K36 at GAL4 is permanent and that its repressive effects are
overcome through the recruitment of transcriptional activa-
tors. It is also possible that a demethylating enzyme exists.
Finally, there may be a mechanism whereby methylated his-
tones are replaced by unmethylated ones upon transcriptional
activation (1).
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